Homogeneous asymmetric hydrogenation using phosphine ligands of transition metals
AssigneeChirotech Technology Limited
InventorsMark Joseph Burk, Frank Bienewald, Martin Edward Fox, Antonio Zanotti-Gerosa
Life of this patent
Estimating the term…
Loading patent…
AssigneeChirotech Technology Limited
InventorsMark Joseph Burk, Frank Bienewald, Martin Edward Fox, Antonio Zanotti-Gerosa
Estimating the term…
A process for the preparation of an enantiomerically enriched 2-substituted succinic acid derivative of formula 2, which comprises asymmetric hydrogenation of the dehydro precursor of formula 7 or 8, or a mixture thereof wherein R1 and R2 are independently H, a salt-forming cation, or an organic group of up to 30 C atoms, and R3 and R4 are independently H or an organic group of up to 30 C atoms, provided that R3 and R4 are not both H, in the presence of a transition metal complex of a chiral phosphine ligand having the partial formula 10 wherein n is 0 to 6 and R represents at least one non-hydrogen organic group of up to 30 C atoms.
A process for the preparation of an enantiomerically enriched 2-substituted succinic acid deriviative of formula 2, which comprises asymmetric hydrogenation of the dehydro precursor of formula 7 or 8, or a mixture thereof
A process for the preparation of an enantiomerically enriched 2-substituted succinic acid derivative of formula 2, which comprises asymmetric hydrogenation of the dehydro precursor of formula 7 or 8, or a mixture thereof
Dependencies are inferred from the claim text.